A study of COTI-219.

Trial Profile

A study of COTI-219.

Phase of Trial: Phase I

Latest Information Update: 15 Nov 2017

At a glance

  • Drugs COTI 219 (Primary)
  • Indications Cancer; Colorectal cancer; Small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Nov 2017 According to a Critical Outcome Technologies media release, the company plans to file an IND in early 2018.
    • 16 Jan 2017 Indications are assumed from RDI profile.
    • 16 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top